Yungjin Pharm said in a regulatory filing on June 3 that it will invest 17.4 billion won to build a plant producing cephalosporin antibiotics by March next year.
“To meet the growing demand overseas, we will build a new GMP plant,’’ a company official said.
The plant will be built in Namyang, Kyunggi Province.
To this end, Yungin is scheduled to seek its paid-in capital increase by 35 ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.